PRIDCO also reports that 64 plants operate in Puerto Rico in medicinal and botanical manufacturing, pharmaceutical preparation manufacturing, and in-vitro diagnostic substance manufacturing. Sixty-nine percent of them are subsidiaries of U.S. firms. Thirteen firms run at least one operation in Puerto Rico. They are: Johnson & Johnson, Bristol-Myers Co., Astra Zeneca PLC, Pharmacia Corp., Baxter Intl., Inc., Becton-Dickinson & Co., Cardinal Health Inc., Eli Lilly & Co., Procter & Gamble Co., Schering-Plough Corp., Warner-Lambert Co., Merck & Co., Inc., Pfizer Inc., and Wyeth.
Pharma market in Puerto Rico
A recent article in the Puerto Rico Herald said that nine major Puerto Rico drug manufacturers reported $24.3 billion in sales for the first quarter of this year. The newspaper reported that sales were flat compared with the fourth quarter of 2004, with profits down 4.2%. Some medicines manufactured and packaged in Puerto Rico showed considerable losses during this time period because of competition starting in 2004 from generics in the U.S. market. The best-selling pharmaceutical product from Puerto Rico is Pfizer's Lipitor.
Pharma market in Puerto Rico
A recent article in the Puerto Rico Herald said that nine major Puerto Rico drug manufacturers reported $24.3 billion in sales for the first quarter of this year. The newspaper reported that sales were flat compared with the fourth quarter of 2004, with profits down 4.2%. Some medicines manufactured and packaged in Puerto Rico showed considerable losses during this time period because of competition starting in 2004 from generics in the U.S. market. The best-selling pharmaceutical product from Puerto Rico is Pfizer's Lipitor.
